Background. Dextromethorphan is a noncompetitive N-methyl D-aspartate receptor antagonist that is clinically feasible for relieving the opioid withdrawal symptoms. This study compares the efficacy of a combination therapy with dextromethorphan and clonidine to treatment with clonidine alone. Methods and Materials. In this double-blind randomized clinical trial, patients were selected from inpatients of detox and rehabilitation ward of Razi Hospital, Tabriz, Iran. They were randomly allocated to two groups receiving either clonidine (0.4-1.2 mg/day) or clonidine and dextromethorphan (300 mg/day). Withdrawal symptoms were evaluated in the first day of admission and again 24, 48, and 72 hours later. Results. Thirty male patients completed the trial in each group. Withdrawal symptoms began to decrease in the second day in patients receiving dextromethorphan and clonidine while patients receiving clonidine experienced the more severe symptoms in 72 hours. Analysis of variance of the symptom severity score revealed a significant group × time interaction (F = 14.25; P < 0.001), so that patients receiving dextromethorphan plus clonidine had milder symptoms during three days in all of the measurements compared to clonidine group. Conclusion. Combination therapy of dextromethorphan and clonidine would result in milder opioid withdrawal symptoms compared to clonidine alone with a reduction beginning at the second day.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3706070 | PMC |
| http://dx.doi.org/10.1155/2013/546030 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Delayed Acetaminophen Absorption Resulting in Acute Liver Failure.
Case Rep Crit Care
May 2022
New South Wales Poisons Information Centre, Children's Hospital at Westmead, NSW, Australia.
Article Synopsis
- * A case study of a 43-year-old woman showed that despite her acetaminophen level being initially below the nomogram line, she developed severe liver failure due to delayed absorption caused by medications that slow gastric emptying, including clonidine.
- * The case emphasizes the potential risks of coingesting drugs that affect gastric emptying, as they can alter the pharmacokinetics of acetaminophen and lead to unexpected toxicity.
Evidence for the Efficacy of Systemic Opioid-Sparing Analgesics in Pediatric Surgical Populations: A Systematic Review.
Anesth Analg
November 2017
From the *Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Boston, Massachusetts; and †Department of Pediatric Anesthesiology, Ann & Robert H. Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
While a large number of studies has examined the efficacy of opioid-sparing analgesics in adult surgical populations, fewer studies are available to guide postoperative pain treatment in pediatric patients. We systematically reviewed available publications on the use of systemic nonopioid agents for postoperative analgesia in pediatric surgical populations. A comprehensive literature search identified meta-analyses and randomized controlled trials (RCTs) assessing the effects of systemic, nonopioid agents on postoperative narcotic requirements or pain scores in pediatric surgical populations.
View Article and Find Full Text PDFDifferent interventions in preventing opioid-induced cough: a meta-analysis.
J Clin Anesth
November 2016
Department of Anesthesiology, West China Second Hospital of Sichuan University, Key Laboratory of Birth Defects and Related Diseases of Women and Children, Sichuan University, Ministry of Education, Chengdu 610041, China. Electronic address:
Background: Cough is one of the most common complications of opioids. Many studies have evaluated the effect of various drugs in preventing opioid-induced cough (OIC). However, there is existing controversy about those reports.
View Article and Find Full Text PDFPatient-tailored combinations of systemic and topical preparations for localized peripheral neuropathic pain: a two-case report.
J Pain Palliat Care Pharmacother
March 2015
This report describes two patients with peripheral neuropathic pain (PNP): a 43-year-old man with upper leg PNP and a 75-year-old woman with post herpetic neuralgia of the perineum and vagina. Pain was inadequately managed in both patients for a long time. A patient-tailored approach, including a combination of systemic and topical compounds, required multiple adjustments for each patient before finally achieving adequate pain control.
View Article and Find Full Text PDFCommon ocular effects reported to a poison control center after systemic absorption of drugs in therapeutic and toxic doses.
Curr Opin Ophthalmol
November 2014
aRegional Poison Control Center, Children's of Alabama bDepartment of Pediatrics, University of Alabama Birmingham School of Medicine, Birmingham, Alabama, USA.
Purpose Of Review: Ocular effects resulting from medications assist toxicologists in determining substances involved when treating a poisoned patient. The intention of this review is to discuss the most common ocular effects, the medications that cause them, and the mechanisms by which they occur.
Recent Findings: According to National Poison Data System, the most common reported ocular effects following a drug ingestion/injection/inhalation are mydriasis, miosis, and nystagmus.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!